Estados financieros detallados de Autolus Therapeutics plc (AUTL): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Autolus Therapeutics plc registró ingresos de $75.6M en el último ejercicio fiscal, con un CAGR de 5 años del 113.2%.
Márgenes de los últimos 12 meses: margen bruto 15.7%, margen operativo -210.8%, margen neto -238.6%.
Al precio actual de $1.87, AUTL presenta beneficios negativos (P/E no significativo) y un ROE del -178.58%. La capitalización bursátil es de $498M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | $1.2M | $1.7M | $1.0M | $2.9M | $1.7M | $1.5M | $6.2M | $1.7M | $10.1M | $75.6M |
| Coste de Ventas | $478000 | $1.0M | $48.3M | $105.4M | $134.9M | 0 | 0 | 0 | $141.0M | $96.6M |
| Beneficio Bruto | $734000 | $684000 | -$47.3M | -$102.5M | -$133.2M | $1.5M | $6.2M | $1.7M | -$130.9M | -$21.0M |
| I+D | $10.4M | $16.0M | $24.6M | $105.6M | $135.0M | $110.8M | $117.4M | $130.5M | $158.1M | $128.6M |
| Generales y Administrativos | $5.2M | $9.1M | $16.8M | $39.5M | $35.0M | $31.9M | $31.9M | $46.7M | 0 | $131.8M |
| Gastos Operativos | $15.6M | $25.1M | $41.5M | $145.1M | $170.0M | $141.9M | $149.1M | $181.4M | $110.5M | $260.4M |
| Beneficio Operativo | -$14.4M | -$23.4M | -$57.5M | -$247.6M | -$303.1M | -$140.4M | -$142.9M | -$179.7M | -$241.4M | -$281.4M |
| EBITDA | -$13.9M | -$22.4M | -$50.3M | -$137.4M | -$162.6M | -$132.5M | -$132.2M | -$156.8M | -$233.1M | -$250.3M |
| Gastos por Intereses | 0 | 0 | $12667 | 0 | 0 | $1.1M | $8.9M | $45.1M | $9.3M | $36.8M |
| Beneficio Antes de Impuestos | -$14.3M | -$23.4M | -$36.3M | -$108.7M | -$166.3M | -$142.0M | -$148.6M | -$208.4M | -$219.1M | -$296.8M |
| Impuestos | -$1.8M | -$3.7M | -$5.2M | $15.2M | -$24.2M | $58000 | $272000 | -$19000 | $1.5M | -$8.6M |
| Beneficio Neto | -$12.6M | -$19.7M | -$31.1M | -$123.8M | -$142.1M | -$142.1M | -$148.8M | -$208.4M | -$220.7M | -$288.2M |
| BPA | $-0.91 | $-1.43 | $-0.99 | $-2.88 | $-2.76 | $-1.97 | $-1.57 | $-1.20 | $-0.87 | $-1.08 |
| BPA Diluido | $-0.91 | $-1.43 | $-0.99 | $-2.88 | $-2.76 | $-1.97 | $-1.57 | $-1.20 | $-0.87 | $-1.08 |
| Acciones en Circulación (Diluidas) | $13.8M | $13.8M | $31.6M | $43.1M | $51.6M | $72.1M | $95.0M | $173.9M | $255.2M | $266.1M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $21.2M | $24.3M | $26.2M | $45.7M |
| Beneficio Bruto | -$7.4M | -$1.0M | $1.6M | $25.2M |
| Beneficio Operativo | -$71.6M | -$72.4M | -$59.5M | -$43.8M |
| EBITDA | -$64.7M | -$66.0M | -$56.9M | -$33.8M |
| Beneficio Neto | -$79.1M | -$90.2M | -$71.6M | -$39.1M |
| BPA | $-0.30 | $-0.34 | $-0.27 | $-0.15 |
| BPA Diluido | $-0.30 | $-0.34 | $-0.27 | $-0.15 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $28.1M | $137.1M | $189.3M | $211.4M | $154.1M | $310.3M | $382.4M | $239.6M | $227.4M | $104.1M |
| Inversiones a Corto | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $360.6M | $196.6M |
| Cuentas por Cobrar | $2.2M | $4.7M | $9.3M | $30.5M | $29.7M | $68000 | $29.0M | $1.0M | $48.2M | $75.8M |
| Inventario | 0 | 0 | $2.2M | 0 | 0 | 0 | 0 | 0 | $4.1M | $33.2M |
| Activos Corrientes | $30.9M | $142.5M | $199.1M | $249.3M | $194.0M | $347.0M | $425.8M | $275.3M | $660.9M | $435.9M |
| Inmovilizado Material | $3.3M | $6.2M | $9.2M | $51.6M | $89.7M | $52.3M | $58.4M | $95.7M | $105.1M | $128.5M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | $9.5M | 0 | $9.3M | $254000 | $158000 | $65000 | 0 | 0 | $12.4M | $19.8M |
| Activos Totales | $34.2M | $148.7M | $217.7M | $303.5M | $294.2M | $405.6M | $490.3M | $375.4M | $782.7M | $589.1M |
| Cuentas por Pagar | $1.4M | $1.9M | $3.0M | 0 | $2.3M | $431000 | $531000 | $103000 | $2.0M | $3.1M |
| Deuda a Corto | 0 | 0 | 0 | $2.5M | $3.6M | 0 | 0 | 0 | 0 | $14.6M |
| Pasivos Corrientes | $2.7M | $5.0M | $12.5M | $25.0M | $33.6M | $28.6M | $46.4M | $44.7M | $60.7M | $73.4M |
| Deuda a Largo | 0 | 0 | $221000 | 0 | 0 | $47.0M | 0 | 0 | 0 | $270.2M |
| Pasivos Totales | $3.5M | $6.1M | $12.5M | $48.7M | $84.2M | $92.2M | $191.6M | $263.9M | $355.4M | $410.9M |
| Reservas | -$28.2M | -$47.9M | $163.8M | -$237.2M | -$379.2M | -$521.3M | -$670.2M | -$878.6M | -$1.10B | -$1.39B |
| Patrimonio Neto | $30.7M | $142.6M | $205.1M | $254.8M | $210.0M | $313.3M | $298.7M | $111.5M | $427.3M | $178.1M |
| Deuda Total | $188000 | $265000 | $221000 | $26.2M | $54.2M | $68.0M | $24.3M | $53.0M | $52.6M | $351.6M |
| Deuda Neta | -$27.9M | -$136.8M | -$189.1M | -$185.2M | -$99.9M | -$242.3M | -$358.2M | -$186.6M | -$535.4M | $50.9M |
| Capital Circulante | $28.2M | $137.4M | $186.6M | $224.3M | $160.3M | $318.4M | $379.4M | $230.6M | $600.2M | $362.5M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $86.1M | $104.1M | $130.9M | $171.4M |
| Activos Totales | $661.9M | $589.1M | $527.1M | $493.2M |
| Pasivos Totales | $396.5M | $410.9M | $418.2M | $418.4M |
| Patrimonio Neto | $265.5M | $178.1M | $108.8M | $74.8M |
| Deuda Total | $65.8M | $351.6M | $80.0M | $83.5M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$12.6M | -$19.7M | -$31.1M | -$123.8M | -$142.1M | -$142.1M | -$148.8M | -$208.4M | -$220.7M | -$287.5M |
| Amortizaciones | $478000 | $1.0M | $1.1M | $4.6M | $5.7M | $8.5M | $7.4M | $6.6M | $7.7M | $9.8M |
| Compensación en Acciones | $2.3M | $3.2M | $5.0M | $30.2M | $20.1M | $9.9M | $12.0M | $11.2M | $15.5M | $14.4M |
| Cambio en Capital Circulante | -$1.2M | -$795000 | $5.4M | -$16.2M | $1.4M | $4.1M | $4.0M | $292000 | -$23.7M | -$52.1M |
| Flujo de Caja Operativo | -$9.8M | -$16.4M | -$25.8M | -$101.5M | -$117.8M | -$117.9M | -$112.3M | -$145.6M | -$206.3M | -$283.6M |
| Inversiones (CapEx) | -$1.9M | -$2.9M | -$8.8M | -$18.7M | -$14.7M | -$8.9M | -$10.8M | -$11.0M | -$34.8M | -$27.1M |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | -$3.2M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$11.7M | -$19.2M | -$34.6M | -$120.2M | -$132.4M | -$126.7M | -$123.1M | -$156.6M | -$241.1M | -$310.7M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$67.9M | -$67.3M | -$65.3M | -$25.1M |
| Inversiones (CapEx) | $15.5M | -$23.8M | -$2.7M | -$913000 |
| Flujo de Caja Libre | -$52.4M | -$91.1M | -$68.0M | -$26.0M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $3.8M | $3.4M | $3.6M | $4.6M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +39.7% | -38.3% | +178.2% | -41.0% | -12.1% | +311.0% | -72.6% | +496.0% | +646.7% |
| Crecimiento Beneficio Neto (anual) | | -57.2% | -57.7% | -298.0% | -14.7% | -0.0% | -4.7% | -40.0% | -5.9% | -30.6% |
| Crecimiento BPA (anual) | | -57.1% | +30.8% | -190.9% | +4.2% | +28.6% | +20.3% | +23.6% | +27.5% | -24.1% |
| Cambio en Acciones (anual) | | +0.0% | +129.0% | +36.5% | +19.7% | +39.8% | +31.8% | +83.1% | +46.7% | +4.3% |
| Crecimiento FCF (anual) | | -64.4% | -80.0% | -247.1% | -10.2% | +4.3% | +2.8% | -27.1% | -54.0% | -28.9% |
| Margen Bruto | 60.6% | 40.4% | -4520.4% | -3525.1% | -7765.2% | 100.0% | 100.0% | 100.0% | -1293.5% | -27.8% |
| Margen Operativo | -1186.1% | -1383.2% | -5503.7% | -8513.8% | -17675.4% | -9314.8% | -2307.0% | -10583.1% | -2385.6% | -372.4% |
| Margen EBITDA | -1146.7% | -1323.6% | -4813.9% | -4724.8% | -9479.8% | -8790.6% | -2135.0% | -9232.6% | -2303.1% | -331.2% |
| Margen Neto | -1035.5% | -1165.2% | -2976.5% | -4258.9% | -8285.4% | -9429.1% | -2403.0% | -12272.3% | -2180.5% | -381.4% |
| Margen FCF | -965.7% | -1136.2% | -3311.7% | -4131.8% | -7722.4% | -8408.6% | -1988.2% | -9221.0% | -2382.3% | -411.2% |
| Tasa Impositiva Efectiva | 12.4% | 15.6% | 14.3% | -13.9% | 14.5% | -0.0% | -0.2% | 0.0% | -0.7% | 2.9% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-0.85 | $-1.40 | $-1.10 | $-2.79 | $-2.57 | $-1.76 | $-1.30 | $-0.90 | $-0.94 | $-1.17 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $13.8M | $13.8M | $31.6M | $43.1M | $51.6M | $72.1M | $95.0M | $173.9M | $255.2M | $266.1M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -178.58% |
| Rentabilidad sobre capital invertido | -57.49% |
| Rentabilidad sobre activos | -56.77% |
| Margen bruto | 15.66% |
| Margen operativo | -210.76% |
| Margen neto | -238.62% |
Salud financiera
| Deuda / Patrimonio | 1.12 |
| Ratio corriente | 4.89 |
| Piotroski F-Score | 3 |
| Altman Z-Score | -3.23 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -27.47 | -17.48 | -30.95 | -4.58 | -3.24 | -2.63 | -1.21 | -5.37 | -2.70 | -1.84 |
| P/VC | 11.23 | 2.42 | 4.71 | 2.23 | 2.19 | 1.19 | 0.60 | 10.05 | 1.40 | 2.97 |
| P/V | 284.31 | 203.53 | 924.97 | 195.48 | 268.76 | 248.25 | 29.14 | 659.71 | 59.25 | 7.01 |
| Margen Bruto | 60.6% | 40.4% | -4520.4% | -3525.1% | -7765.2% | 100.0% | 100.0% | 100.0% | -1293.5% | -27.8% |
| Margen Operativo | -1186.1% | -1383.2% | -5503.7% | -8513.8% | -17675.4% | -9314.8% | -2307.0% | -10583.1% | -2385.6% | -372.4% |
| Margen Neto | -1035.5% | -1165.2% | -2976.5% | -4258.9% | -8285.4% | -9429.1% | -2403.0% | -12272.3% | -2180.5% | -381.4% |